U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093606) titled 'Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura' on July 23.
Brief Summary: this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Study Start Date: July 14
Study Type: INTERVENTIONAL
Condition:
ITP - Immune Thrombocytopenia
Intervention:
DRUG: Eltrombopag
ITP patients will receive Eltrombopag and evulate occurance of liver disordres .
Recruitment Status: RECRUITING
Sponsor: Sohag University
Information provided by (Responsible Party): Peter Adel Alfy, Sohag University
Published by HT Digital Content Services with permission...